Ezetimibe
NDC 50268-298, Ezetimibe, tablet, from AvPAK.
- Product NDC
- 50268-298
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208803
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EZETIMIBE10 mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE]; Dietary Cholesterol Absorption Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-298-12 | 50268029812 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-298-12) / 1 TABLET in 1 BLISTER PACK (50268-298-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6fcbfbd9-6e09-8224-e053-2a91aa0a8226NADAC price for package 50268029812
GET /v1/drugs/nadac/50268029812
Use it
Look up 50268-298 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-298. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.